|
1
|
WHO. Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
2012
|
|
2
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
4
|
IARC. Cancer Epidemiology Database.
GLOBOCAN. 2002
|
|
5
|
IARC. Cancer Epidemiology Database.
GLOBOCAN. 2008
|
|
6
|
Monsuez JJ, Charniot JC, Vignat N and
Artigou JY: Cardiac side-effects of cancer chemotherapy. Int J
Cardiol. 144:3–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhat TA and Singh RP: Tumor angiogenesis -
a potential target in cancer chemoprevention. Food Chem Toxicol.
46:1334–1345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sagar SM, Yance D and Wong R: Natural
health products that inhibit angiogenesis: a potential source for
investigational new agents to treat cancer - Part 1. Curr Oncol.
13:14–26. 2006.
|
|
9
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tassi E and Wellstein A: Tumor
angiogenesis: initiation and targeting - therapeutic targeting of
an FGF-binding protein, an angiogenic switch molecule, and
indicator of early stages of gastrointestinal adenocarcinomas.
Cancer Res Treat. 38:189–197. 2006. View Article : Google Scholar
|
|
14
|
Weidner N, Carroll P, Flax J, Blumenfeld W
and Folkman J: Tumor angiogenesis correlates with metastasis in
invasive prostate carcinoma. Am J Pathol. 143:401–409.
1993.PubMed/NCBI
|
|
15
|
Maeda K, Chung YS, Takatsuka S, et al:
Tumor angiogenesis as a predictor of recurrence in gastric
carcinoma. J Clin Oncol. 13:477–481. 1995.PubMed/NCBI
|
|
16
|
Choi HJ, Hyun MS, Jung GJ, Kim SS and Hong
SH: Tumor angiogenesis as a prognostic predictor in colorectal
carcinoma with special reference to mode of metastasis and
recurrence. Oncology. 55:575–581. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frank RE, Saclarides TJ, Leurgans S,
Speziale NJ, Drab EA and Rubin DB: Tumor angiogenesis as a
predictor of recurrence and survival in patients with node-negative
colon cancer. Ann Surg. 222:695–699. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Folkman J and Cotran R: Relation of
vascular proliferation to tumor growth. Int Rev Exp Pathol.
16:207–248. 1976.PubMed/NCBI
|
|
19
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis - correlation in invasive
breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Keshavarz M, Mostafaie A, Mansouri K,
Bidmeshkipour A, Motlagh HR and Parvaneh S: In vitro and ex vivo
antiangiogenic activity of Salvia officinalis. Phytother
Res. 24:1526–1531. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu J, Zhang K, Nam S, Anderson RA, Jove R
and Wen W: Novel angiogenesis inhibitory activity in cinnamon
extract blocks VEGFR2 kinase and downstream signaling.
Carcinogenesis. 31:481–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nassar ZD, Aisha AF, Ahamed MB, et al:
Antiangiogenic properties of Koetjapic acid, a natural triterpene
isolated from Sandoricum koetjaoe Merr. Cancer Cell Int.
11:122011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ren J, Zheng C, Feng G, et al: Inhibitory
effect of extract of fungi of Huaier on hepatocellular carcinoma
cells. J Huazhong Univ Sci Technolog Med Sci. 29:198–201. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu X, Wei Q, Wang K, et al: Anticancer
effects of Huaier are associated with down-regulation of P53. Asian
Pac J Cancer Prev. 12:2251–2254. 2011.PubMed/NCBI
|
|
25
|
Zhang N, Kong X, Yan S, Yuan C and Yang Q:
Huaier aqueous extract inhibits proliferation of breast cancer
cells by inducing apoptosis. Cancer Sci. 101:2375–2383. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: a convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu J, Lu Y, Gao M and Zhang W: The
advances of angiogenesis assay models. Chin Pharmacol Bull.
24:112008.
|
|
28
|
Kruger EA, Duray PH, Tsokos MG, et al:
Endostatin inhibits microvessel formation in the ex vivo rat aortic
ring angiogenesis assay. Biochem Biophys Res Commun. 268:183–191.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Patsouris D, Neels JG, Fan W, Li PP,
Nguyen MT and Olefsky JM: Glucocorticoids and thiazolidinediones
interfere with adipocyte-mediated macrophage chemotaxis and
recruitment. J Biol Chem. 284:31223–31235. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu B, Du Q, Shen K and Xu L: Principles
and scientific basis of traditional Chinese medicine in cancer
treatment. J Bioanal Biomed S. 6:22012.
|
|
31
|
Liu Y, Ling Y, Hu W, et al: The herb
medicine formula ‘Chong Lou Fu Fang’ increases the cytotoxicity of
chemotherapeutic agents and down-regulates the expression of
chemotherapeutic agent resistance-related genes in human gastric
cancer cells in vitro. Evid Based Complement Alternat Med.
2011:8342312011.
|
|
32
|
Ostermann T, Raak C and Bussing A:
Survival of cancer patients treated with mistletoe extract
(Iscador): a systematic literature review. BMC Cancer. 9:4512009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abdollahi A, Lipson KE, Sckell A, et al:
Combined therapy with direct and indirect angiogenesis inhibition
results in enhanced antiangiogenic and antitumor effects. Cancer
Res. 63:8890–8898. 2003.PubMed/NCBI
|
|
34
|
Folkman J, Hahnfeldt P and Hlatky L: The
logic of anti-angiogenic gene therapy. Cold Spring Harbor Monograph
Archive. 36:527–543. 1999.
|
|
35
|
Kamba T and McDonald DM: Mechanisms of
adverse effects of anti-VEGF therapy for cancer. Br J Cancer.
96:1788–1795. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wen W, Lu J, Zhang K and Chen S: Grape
seed extract inhibits angiogenesis via suppression of the vascular
endothelial growth factor receptor signaling pathway. Cancer Prev
Res. 1:554–561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang SJ, Sun B, Cheng ZX, et al:
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by
targeting the NF-kappaB pathway. Cancer Chemother Pharmacol.
68:1421–1430. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brugarolas J, Moberg K, Boyd SD, Taya Y,
Jacks T and Lees JA: Inhibition of cyclin-dependent kinase 2 by p21
is necessary for retinoblastoma protein-mediated G1 arrest after
γ-irradiation. Proc Natl Acad Sci USA. 96:1002–1007.
1999.PubMed/NCBI
|
|
39
|
Neufeld G, Cohen T, Gengrinovitch S and
Poltorak Z: Vascular endothelial growth factor (VEGF) and its
receptors. FASEB J. 13:9–22. 1999.PubMed/NCBI
|
|
40
|
Paley PJ, Staskus KA, Gebhard K, et al:
Vascular endothelial growth factor expression in early stage
ovarian carcinoma. Cancer. 80:98–106. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang XM, Wang YS, Zhang J, et al: Role of
PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of
HIF-1alpha and VEGF in laser-induced rat choroidal
neovascularization. Invest Ophthalmol Vis Sci. 50:1873–1879. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Richard DE, Berra E, Gothie E, Roux D and
Pouyssegur J: p42/p44 mitogen-activated protein kinases
phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and
enhance the transcriptional activity of HIF-1. J Biol Chem.
274:32631–32637. 1999. View Article : Google Scholar
|
|
43
|
Wang FS, Wang CJ, Chen YJ, et al: Ras
induction of superoxide activates ERK-dependent angiogenic
transcription factor HIF-1alpha and VEGF-A expression in shock
wave-stimulated osteoblasts. J Biol Chem. 279:10331–10337. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kunimasa K, Ahn MR, Kobayashi T, et al:
Brazilian propolis suppresses angiogenesis by inducing apoptosis in
tube-forming endothelial cells through inactivation of survival
signal ERK1/2. Evid Based Complement Alternat Med. 2011:8707532011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang C, Rajfur Z, Borchers C, Schaller MD
and Jacobson K: JNK phosphorylates paxillin and regulates cell
migration. Nature. 424:219–223. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yahata Y, Shirakata Y, Tokumaru S, et al:
Nuclear translocation of phosphorylated STAT3 is essential for
vascular endothelial growth factor-induced human dermal
microvascular endothelial cell migration and tube formation. J Biol
Chem. 278:40026–40031. 2003. View Article : Google Scholar
|
|
47
|
Collins T, Read MA, Neish AS, Whitley MZ,
Thanos D and Maniatis T: Transcriptional regulation of endothelial
cell adhesion molecules: NF-kappa B and cytokine-inducible
enhancers. FASEB J. 9:899–909. 1995.PubMed/NCBI
|
